Welcome to our dedicated page for Arista Networks SEC filings (Ticker: ANET), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Arista Networks builds the Ethernet switches and EOS software that keep hyperscale data centers moving at terabit speed鈥攜et its regulatory disclosures hold details just as critical as its technology. From customer concentration in cloud giants to the cadence of new product releases, Arista Networks SEC filings reveal the data networking story behind the numbers.
Stock Titan turns every document鈥攆rom an Arista Networks annual report 10-K simplified to an Arista Networks quarterly earnings report 10-Q filing鈥攊nto clear, bite-size intelligence. Our AI-powered summaries spotlight revenue by product family, supply-chain dependencies, and competitive pressures in seconds, while real-time alerts surface Arista Networks Form 4 insider transactions real-time. Need the fine print? Click straight into the source for Arista Networks proxy statement executive compensation, Arista Networks 8-K material events explained, or any other form the moment it hits EDGAR.
Whether you鈥檙e monitoring Arista Networks insider trading Form 4 transactions, seeking Arista Networks earnings report filing analysis, or simply understanding Arista Networks SEC documents with AI, our platform delivers. Investors track executive stock awards through Arista Networks executive stock transactions Form 4, compare R&D trends across quarters, and flag contractual risks hidden deep in footnotes鈥攚ithout wading through hundreds of pages. Complex networking company disclosures, clarified: that鈥檚 the Stock Titan advantage.
Schedule 13D/A Amendment 10 highlights: Three related investors鈥�Parag Saxena, Vedanta Partners, LLC and Vedanta Associates, L.P.鈥攗pdated their beneficial ownership in Reviva Pharmaceuticals Holdings, Inc. (RVPH) as of the event date 27 June 2025 and filing date 1 July 2025.
- Parag Saxena now reports 6,259,806 shares, or 8.7 % of RVPH鈥檚 68,003,613 outstanding shares. His stake includes 21,400 vested stock options and a mix of common shares, warrants and pre-funded warrants.
- Vedanta Partners is shown with 5,367,069 shares, equating to 7.5 % of the class.
- Vedanta Associates reports 3,408,401 shares, or 4.8 %. Because the holding fell below 5 %, Item 5(e) states the entity ceased to be a 5 % beneficial owner on 27 June 2025.
- No transactions were effected in the past 60 days; changes arise from share count dynamics and warrant/option calculations. Certain warrants are subject to a 4.99 % blocker that limits exercise to avoid crossing ownership thresholds.
Implications for investors: The overall 鈥淰edanta group鈥� remains a significant insider bloc (>8 %) capable of influencing corporate actions. However, one vehicle dropping below 5 % reduces mandatory reporting frequency for that entity and may signal distribution of ownership or passive dilution. The filing contains no operational, financial or strategic updates from RVPH itself.
The Form 4 filing discloses that Hannah A. Valantine, M.D., a director of BridgeBio Pharma, Inc. (BBIO), sold a total of 4,707 shares of BBIO common stock on 26-Jun-2025 at weighted-average prices ranging from $44.01 to $44.14 per share.
- Direct holdings: Two separate sales of 876 shares (avg. $44.1099) and 1,542 shares (avg. $44.01) reduced Dr. Valantine鈥檚 direct ownership from 9,883 shares to 7,465 shares.
- Indirect (spousal) holdings: Two sales of 398 shares (avg. $44.1263) and 1,891 shares (avg. $44.0303) lowered spousal indirect holdings from 2,687 shares to 398 shares.
- Total remaining beneficial ownership: 7,863 shares (7,465 direct + 398 indirect).
- The filing uses transaction code 鈥�S鈥� indicating open-market sales. Weighted-average price ranges are provided; detailed price breakdowns are available upon request, per footnotes 1 and 2.
No derivative security transactions were reported. No 10b5-1 trading plan is indicated, and there are no acquisitions or option exercises in this filing.
The magnitude of the sale represents a partial reduction of the director鈥檚 position rather than a complete exit, and the company鈥檚 overall share count is unaffected. The information is limited to insider activity; it does not include operational or financial performance data.
Arista Networks, Inc. (ANET) 鈥� Form 144 filing dated 27 June 2025
The notice discloses that President & CEO Jayshree Ullal, acting as trustee for The Ishan Nagpal Trust, intends to sell 8,724 common shares of Arista on or about 27 June 2025 through J.P. Morgan Securities LLC on the NYSE. The shares, originally obtained via stock-option exercise on 1 Jan 2013, carry an aggregate market value of $886,295. The filing cites shares outstanding of 1,255,921,431, implying the proposed sale represents an immaterial fraction of the float.
The form also lists insider dispositions over the preceding three months by multiple Ullal-related trusts and by Jayshree Ullal personally. In total, six separate sales between 26 June 2025 and the filing date amounted to 117,782 shares for gross proceeds of approximately $12.0 million. All dispositions appear to have been executed under Rule 144, and the filer affirms no possession of undisclosed material adverse information. A Rule 10b5-1 trading plan was adopted on 13 Dec 2024.
Key takeaways for investors:
- The CEO continues to reduce her personal and family-trust holdings, though the new sale is modest versus total ownership.
- Sales are covered by a pre-arranged 10b5-1 plan, limiting inference of timing-related concerns.
- No operational or financial performance data are provided; the filing is strictly a notice of proposed insider sale.
Arista Networks Form 144 filing discloses a proposed sale of securities by Jayshree Ullal, Officer and Director, through The Ishan Nagpal Trust. Key details:
- Proposed sale of 1,276 shares of common stock with aggregate market value of $124,193
- Sale to be executed through J.P. Morgan Securities LLC on NYSE, planned for June 26, 2025
- Shares originated from stock option exercises in 2013 and were transferred to the Trust between January-December 2013
- Sale is conducted under a Rule 10b5-1 trading plan adopted on December 13, 2024
- Total shares outstanding: 1,255,921,431
The filing confirms no material adverse information is known and unreported, and no other securities were sold by the insider in the past 3 months. This planned sale represents a minimal portion (approximately 0.0001%) of total outstanding shares.
Arista Networks insider trading notification: CEO Jayshree Ullal plans to sell 106,766 shares with an aggregate market value of $10,391,534 through J.P. Morgan Securities on the NYSE, scheduled for June 26, 2025.
The shares to be sold were acquired through multiple transactions:
- 12,000 shares via stock option exercise on 06/26/2025
- 24,042 shares from PSU vesting on 05/20/2025
- 70,724 shares from RSU grants (various dates between 2021-2023)
The sale is executed under a Rule 10b5-1 trading plan adopted on December 13, 2024. Some transactions will involve cashless option exercises within 3 months of filing. Notably, Ullal has made no other sales in the past 3 months. The filing confirms no knowledge of undisclosed material adverse information regarding Arista's operations.
Form 144 filing for Arista Networks, Inc. (ANET) discloses that Officer and Director Jayshree Ullal plans to sell shares under Rule 144. The notice, dated 26 June 2025, was filed by J.P. Morgan Securities LLC acting as agent and attorney-in-fact.
- Shares to be sold: 669,403 common shares
- Aggregate market value stated: 65,152,993 (currency not specified in the form)
- Approximate sale date: 26 June 2025 on the NYSE
- Broker: J.P. Morgan Securities LLC, 360 Madison Ave., New York, NY 10017
- Shares outstanding (as listed): 1,255,921,431
- Origin of shares: Stock-option exercises originally acquired on 01 Jan 2013 and later transferred to the 2000 Ullal Family Trust
- Rule 10b5-1 plan: Adoption date 13 Dec 2024
No other sales of Arista securities by Ullal were reported during the past three months. The filer represents that no undisclosed material adverse information is known. The transaction represents a sizable insider disposition but is executed under a pre-arranged 10b5-1 trading plan, providing regulatory compliance and signaling advance planning.
Arista Networks insider trading notification: CEO Jayshree Ullal plans to sell 127,580 shares with an aggregate market value of $12,417,361 through J.P. Morgan Securities. The sale is scheduled for June 26, 2025, on the NYSE.
Key details:
- Shares were originally acquired through stock option exercises in 2013
- Sale will be executed by The Adeeti Ullal Trust, with Jayshree Ullal as Trustee
- Transaction follows a Rule 10b5-1 trading plan adopted on December 13, 2024
- Current total shares outstanding: 1,255,921,431
The filing confirms no material adverse information is known by the seller and notes no other sales by the insider in the past 3 months. This planned sale represents approximately 0.01% of total outstanding shares.
Arista Networks insider trading notice: CEO Jayshree Ullal plans to sell 127,580 shares with an aggregate market value of $12,417,361 through J.P. Morgan Securities. The sale is scheduled for June 26, 2025, on the NYSE.
Key details:
- Shares were originally acquired through stock option exercises in 2013 and transferred to The Tarini Ullal Trust
- Sale is being conducted under a Rule 10b5-1 trading plan adopted on December 13, 2024
- Total outstanding shares: 1,255,921,431
- No other sales reported in the past 3 months by the seller
The Form 144 filing confirms the seller has no knowledge of undisclosed material adverse information regarding Arista Networks' operations. The transaction represents approximately 0.01% of total outstanding shares.
Arista Networks insider trading notification: CEO Jayshree Ullal plans to sell 1,276 shares of common stock valued at approximately $124,193 through J.P. Morgan Securities. The sale is scheduled for June 26, 2025 on the NYSE.
Key details:
- Shares were originally acquired through stock option exercise on January 1, 2013
- Sale will be executed by The Shriya Nagpal Trust, with Ullal as Trustee
- Trading plan adopted under Rule 10b5-1 on December 13, 2024
- No other sales reported by the insider in the past 3 months
- Total shares outstanding: 1,255,921,431
This planned sale represents a minimal portion (approximately 0.0001%) of Arista's total outstanding shares. The transaction follows a pre-established trading plan, suggesting routine portfolio management rather than a response to company-specific factors.
FAQ
What is the current stock price of Arista Networks (ANET)?
What is the market cap of Arista Networks (ANET)?
What is the core business of Arista Networks Inc?
How does Arista's network operating system (EOS) enhance its product offerings?
What distinguishes Arista Networks in the competitive networking landscape?
Who are the primary customers of Arista Networks?
What are the key components of Arista Networks' product portfolio?
How does Arista maintain a competitive advantage in its market segment?
What industries are primarily served by Arista Networks?
